Get this report today!
Table of Contents
The cost and time of developing and bringing a drug to market is over $1.3 billion and often takes as long as 15 years, if not longer. Because of this, major pharmaceutical marketers continue to outsource stages of development, and over the years Kalorama Information has observed this process. In past editions of our outsourcing market studies, we found that outsourcing moved from "should" to "must." for manufacturers. This trend has only continued in the past two years.
Contract Research Organizations (CROs) and other entities can expect growing demand for their services. The demand for new drugs remains unabated, but the cost and need to bring those drugs to market is ever-increasing and intensifying. A key cost driver is the large number of failures during the expensive clinical trial phases. Driven by pressures to reduce costs, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry.
Kalorama Information's Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market is the third edition of this study of the drivers for outsourcing drug development, the companies involved in this market and the opportunity for revenues.
As part of its comprehensive coverage of this market, this report contains:
Talk to Alison
00 1 718 618 48 97
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Espicom market intelligence, brought to you by Business Monitor International The Americas Pharmaceuticals & Healthcare Reports feature independent forecasts for drugs and healthcare expenditure and imports ...
REPORT SCOPE INTRODUCTION STUDY GOALS AND OBJECTIVES This BCC Research report, Histone Methyltransferases: Global Markets for Research Tools, Diagnostics and Drug Discovery, provides an overview of the ...
The Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery, preclinical and ...
... Services. Contact him at 1.650.465.0119 Or figure 1. Supply and demand for clinical research personnel (2012/2013) ...
... By activities: - demand planning - clinical trial supply set-up (packaging design, label approval, etc.) - Inventory management - ivr set-up - outsourcing - logistics increasing trend in cts is to take ...
... April 2013 3 overall trend in r&d efficiency (inflation adjusted) jack w. Scannell, alex blanckley, helen boldon & brian warrington. Nature reviews drug discovery 11 ...
Reportlinker.com © Copyright 2013. All rights reserved.